Chromovitrectomy and vital dyes

Hiroshi Enaida, Toshio Hisatomi, shintaro nakao, Yasuhiro Ikeda, Shigeo Yoshida, Tatsuro Ishibashi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.

Original languageEnglish
Pages (from-to)120-125
Number of pages6
JournalDevelopments in Ophthalmology
Volume54
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Coloring Agents
Vitrectomy
Epiretinal Membrane
Triamcinolone Acetonide
Retinal Perforations
Indocyanine Green
Microsurgery
Staining and Labeling
Membranes

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Chromovitrectomy and vital dyes. / Enaida, Hiroshi; Hisatomi, Toshio; nakao, shintaro; Ikeda, Yasuhiro; Yoshida, Shigeo; Ishibashi, Tatsuro.

In: Developments in Ophthalmology, Vol. 54, 01.01.2014, p. 120-125.

Research output: Contribution to journalArticle

Enaida, Hiroshi ; Hisatomi, Toshio ; nakao, shintaro ; Ikeda, Yasuhiro ; Yoshida, Shigeo ; Ishibashi, Tatsuro. / Chromovitrectomy and vital dyes. In: Developments in Ophthalmology. 2014 ; Vol. 54. pp. 120-125.
@article{ca0fd936a4d04f2da3088f3d91c0fcb7,
title = "Chromovitrectomy and vital dyes",
abstract = "It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.",
author = "Hiroshi Enaida and Toshio Hisatomi and shintaro nakao and Yasuhiro Ikeda and Shigeo Yoshida and Tatsuro Ishibashi",
year = "2014",
month = "1",
day = "1",
doi = "10.1159/000360457",
language = "English",
volume = "54",
pages = "120--125",
journal = "Developments in Ophthalmology",
issn = "0250-3751",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Chromovitrectomy and vital dyes

AU - Enaida, Hiroshi

AU - Hisatomi, Toshio

AU - nakao, shintaro

AU - Ikeda, Yasuhiro

AU - Yoshida, Shigeo

AU - Ishibashi, Tatsuro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.

AB - It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.

UR - http://www.scopus.com/inward/record.url?scp=84929518789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929518789&partnerID=8YFLogxK

U2 - 10.1159/000360457

DO - 10.1159/000360457

M3 - Article

C2 - 25196760

AN - SCOPUS:84929518789

VL - 54

SP - 120

EP - 125

JO - Developments in Ophthalmology

JF - Developments in Ophthalmology

SN - 0250-3751

ER -